
Michael Macklin
Assistant Professor of Medicine · University of Chicago Medical Center
Credentials: · · · · · · ·
History
Research
Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics
Review · Pharmaceuticals · 2023 · First of 4 authors · 18 citations
Review · Cells · 2023 · First of 8 authors · Corresponding · 8 citations
Case report · Cureus · 2022 · 4 citations

1 paper

1 paper
- BL
1 paper · 1 as a resident
- BM
1 paper · 1 as a resident

1 paper · 1 as a resident

1 paper

1 paper
- GK
1 paper · 1 as a fellow
Clinical trials
- 2025–2032
Site PI · Recruiting · Phase 1
Allogene Therapeutics
- 2024–2034
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Site PI · Recruiting · Phase 2
Novartis Pharmaceuticals
- 2024–2029
Site PI · Recruiting · Phase 2, Phase 3
Cabaletta Bio


